In healthcare AI, the technology is the easy part. The hard part, the part that decides whether a multimillion-dollar investment delivers anything at all, is the last mile between a tool that works and a tool that changes care, and it is the part that is rarely built. Health systems and technology companies pour capital into AI tools, digital platforms, and care management systems, and then watch the promised value fail to arrive. The reason is not normally the technology itself. It is that the bridge between the technology and actual care delivery was never constructed.
Sarah T. Khan has spent nearly two decades building and scaling clinical operating infrastructure across health systems, Fortune 500 companies, and AI-native health technologies. She not only designs strategies and products, but also makes them operational in the real world. “Bridging clinical ops and emerging tech is not a strategy exercise,” she states. “It’s an execution challenge.” The organizations that realize value are the ones that treat the last mile as the actual work to be done at the ground level rather than an executive-level conversation.
The Pilot Works. The Operations Are Not Ready
The most common pattern in healthcare AI is also the most expensive. An organization runs a pilot, sees remarkable results, and then watches the technology stall the moment it tries to scale. Leaders conclude the tool failed, but in reality, it did not. The tool worked exactly as it did in the pilot. What failed was the operational environment around it, which was never built to support the tool at scale.
Real return comes from constructing the clinical and operational infrastructure around a tool before attempting to scale it. That means workflow integration, accountability matrices that actually drive adoption, training, and performance management built to sustain the change. “Without the foundation,” Khan explains, “even the best AI solutions will fade and not result in value.” A pilot succeeds in a controlled setting precisely because the surrounding complexity has been held at bay. Scaling reintroduces all of it, and a tool dropped into operations that cannot support it does not transform care. It withers – leaving the organization to wrongly blame the technology for a foundation it never poured.
Someone Has to Translate Between Two Languages
The reason healthcare AI stalls is that the people responsible for it are speaking past one another. Technology teams speak in capabilities and go-live dates, but clinical teams speak in outcomes, service, and patient experience. Both are fluent in their own domain, and neither is fluent in the other’s, and the space between those two languages is exactly the gap.
Closing that gap requires someone who can sit in the room and translate in both directions. Khan is direct that this translation is not a soft skill layered on top of the real work. It is the real work. What does the tool actually change at the point of care? What does a physician need to trust it, or a nurse? What is the chief financial officer looking for before agreeing to scale it?
These questions are execution. An AI initiative that answers the technical questions, while leaving the clinical and financial ones unspoken, has not been half-built. It has been built to stall, because the alignment those questions produce is the load-bearing structure of the whole effort.
Go-Live Is a Milestone, Not a Result
Most healthcare AI initiatives treat go-live as the definition of success, as though deploying the technology were the achievement. Go-live is not a success metric. It is a single milestone in a much longer process, and an organization that celebrates it as the destination stops measuring at the exact moment the meaningful work begins.
The metrics that actually matter are clinical quality, improved outcomes, cost reduction, and service – the results that prove the technology changed something real. Khan has seen those results hold, from reducing emergencies by 32% to driving a 95% churn reduction. The reason this worked was that operational go-live was tied to clinical and financial performance from day one rather than treated as an end in itself.
The technology was never the hard part, and deploying it was never the win. The value in healthcare AI lives in the last mile, in the infrastructure built around the tool, the teams aligned across their languages, and the outcomes measured from the first day. Everything depends on that bridge. The most advanced AI in healthcare is worth nothing until it travels the last few feet to the patient it was built to help, and only the infrastructure around it carries it there.
Follow Sarah T. Khan on LinkedIn for insights on healthcare AI, clinical operations, and realizing value between promising technology and measurable outcomes.
